Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for December 2015. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
AMA: Burnout Is Top Issue for Physicians in 2015
WEDNESDAY, Dec. 30, 2015 (HealthDay News) — Physician burnout is the top issue for physicians in 2015, according to a report published by the American Medical Association (AMA).
Characteristics of Compression Stockings May Impact Compliance
WEDNESDAY, Dec. 30, 2015 (HealthDay News) — For patients after deep vein thrombosis (DVT), the most important characteristics of elastic compression stocking (ECS) therapy are risk reduction of post-thrombotic syndrome (PTS) and ability to put on the ECS without assistance, according to a study published online Dec. 16 in the Journal of Thrombosis and Haemostasis.
Secretory IgA Secretion Rate Linked to Risk of Cancer Death
WEDNESDAY, Dec. 30, 2015 (HealthDay News) — Higher secretion rates of secretory immunoglobulin A (sIgA) are associated with decreased risk of cancer death, specifically non-lung cancer, according to a study published online Dec. 23 in PLOS ONE.
Full Text
Third-Trimester Screen Detects Late Alloimmunization
WEDNESDAY, Dec. 30, 2015 (HealthDay News) — Third-trimester screening for alloimmunization in Rhesus c (Rhc)-negative women improves detection and treatment of hemolytic disease of the fetus and newborn (HDFN), according to a study published online Dec. 11 in BJOG: An International Journal of Obstetrics and Gynaecology.
Pre-Op VTE Prophylaxis Safe in Major Cancer Surgery
TUESDAY, Dec. 29, 2015 (HealthDay News) — Preoperative anticoagulation can safely be given to certain patients before major cancer surgery, according to a study published online Dec. 14 in the Journal of the American College of Surgeons.
Early First Cancer in BRCA1/2 Ups Risk in Opposite Breast
TUESDAY, Dec. 29, 2015 (HealthDay News) — BRCA1/2 mutation carriers have increased risk of contralateral breast cancer (CBC), with age at first diagnosis a significant predictor of CBC risk, according to a study published online Dec. 23 in the Journal of Clinical Oncology.
Thyroid CA Patients Report Poor QOL, Despite Good Prognoses
TUESDAY, Dec. 29, 2015 (HealthDay News) — Thyroid cancer survivors report lower quality of life than people who survive other cancers, according to research published in the Dec. 17 issue of Thyroid.
Finances Affect Patient Decisions About Cancer Clinical Trials
TUESDAY, Dec. 29, 2015 (HealthDay News) — For patients with cancer, financial concerns are associated with psychological factors that may impact their quality of decision making regarding clinical trials, according to research published online Dec. 23 in the Journal of Clinical Oncology.
Breast CA Detection Comparable for Ultrasound, Mammography
TUESDAY, Dec. 29, 2015 (HealthDay News) — Ultrasound and mammography appear equally likely to detect breast cancer, according to research published online Dec. 28 in the Journal of the National Cancer Institute.
Second Cancer Risk Persists for Hodgkin’s Lymphoma Survivors
TUESDAY, Dec. 29, 2015 (HealthDay News) — Hodgkin’s lymphoma survivors have an increased risk of a second cancer, with risk still elevated at 35 years or more after treatment, according to a study published in the Dec. 24 issue of the New England Journal of Medicine.
Surgery, Chemo Best for Elderly With Advanced Ovarian Cancer
TUESDAY, Dec. 29, 2015 (HealthDay News) — Primary debulking surgery and chemotherapy in an optimal timeframe is associated with the longest survival time for elderly women with advanced ovarian cancer, according to a study published in the January issue of Obstetrics & Gynecology.
Full Text (subscription or payment may be required)
More Adverse Effects for Medical Castration in Prostate Cancer
TUESDAY, Dec. 29, 2015 (HealthDay News) — For men with metastatic prostate cancer, gonadotropin-releasing hormone agonist (GnRHa) treatment is associated with more adverse effects than orchiectomy, according to a study published online Dec. 23 in JAMA Oncology.
Higher Hospital Prices in U.S. ‘Monopoly Markets’
MONDAY, Dec. 28, 2015 (HealthDay News) — Prices at hospitals in monopoly markets are 15 percent higher than those at hospitals in areas with at least four providers, according to research published recently at the Health Care Pricing Project website.
Modifiable Factors Affect Racial Differences in Lung Cancer
MONDAY, Dec. 28, 2015 (HealthDay News) — Racial/ethnic variation is evident in lung cancer incidence and mortality among postmenopausal women, but other factors may have an influence, according to a study published online Dec. 23 in the Journal of Clinical Oncology.
Patient Education Ups Willingness to Consider Clinical Trials
MONDAY, Dec. 28, 2015 (HealthDay News) — Educational content delivered before the first oncologist visit, in either tailored video or text format, can improve patient willingness to consider participation in clinical trials, according to a study published online Dec. 23 in the Journal of Clinical Oncology.
Both Smoking Bans and Cigarette Taxes Deter Smokers
WEDNESDAY, Dec. 23, 2015 (HealthDay News) — Comprehensive cigarette bans are most effective at limiting smoking among casual users, but high taxes may have the most impact on people who smoke more than a pack a day, according to a study published online Dec. 21 in the American Journal of Public Health.
Full Text (subscription or payment may be required)
ACOG: New Recommendations for Cervical Cancer Screening
WEDNESDAY, Dec. 23, 2015 (HealthDay News) — In a practice bulletin published in the January issue of Obstetrics & Gynecology, new recommendations are presented for cervical cancer screening and prevention.
Full Text (subscription or payment may be required)
Adding Triptorelin to Breast CA Chemo May Up Ovarian Recovery
TUESDAY, Dec. 22, 2015 (HealthDay News) — For premenopausal women with breast cancer, chemotherapy plus the luteinizing hormone-releasing hormone analogue (LHRHa) triptorelin is associated with higher long-term probability of ovarian function recovery, according to a study published in the Dec. 22/29 issue of the Journal of the American Medical Association.
FDA Lifts Ban on Blood Donations by Men Who Have Sex With Men
TUESDAY, Dec. 22, 2015 (HealthDay News) — Men who have sex with men who have abstained from sex for one year will now be allowed to donate blood in the United States. The new policy, announced Monday by the U.S. Food and Drug Administration, reverses a three-decades-old ban on donations from this group of men that traces back to the start of the AIDS epidemic.
CEO Challenge Spurs Workers to Adopt Healthy Practices
TUESDAY, Dec. 22, 2015 (HealthDay News) — The American Cancer Society’s Chief Executive Officers (CEOs) Challenge can increase implementation of health promotion practices, according to a study published in the Dec. 17 issue of the U.S. Centers for Disease Control and Prevention’s Preventing Chronic Disease.
Full Text
Meta-Analysis Confirms miR-21 Expression, Laryngeal CA Link
TUESDAY, Dec. 22, 2015 (HealthDay News) — Expression of miR-21 is associated with laryngeal carcinoma, with high expression related to increased laryngeal cancer risk, according to a meta-analysis published online Dec. 12 in the Journal of Evidence-Based Medicine.
Specific, Consistent ICD-10 Coding Key to Timely Payments
TUESDAY, Dec. 22, 2015 (HealthDay News) — In order to prevent denials, it is important to code correctly within the International Classification of Diseases, Tenth Revision (ICD-10), with specificity matching documentation, according to an article published in Medical Economics.
Hematologists Often Initiate End-of-Life Discussions Too Late
MONDAY, Dec. 21, 2015 (HealthDay News) — U.S. hematologists frequently report that the timing of end of life (EOL) discussions is “too late,” according to a study published online Dec. 21 in JAMA Internal Medicine.
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Periodontal Disease Linked to Increased Breast Cancer Risk
MONDAY, Dec. 21, 2015 (HealthDay News) — Periodontal disease is associated with increased risk of breast cancer among postmenopausal women, according to research published online Dec. 21 in Cancer, Epidemiology, Biomarkers & Prevention.
Pembrolizumab Shows Promise in Metastatic NSCLC
MONDAY, Dec. 21, 2015 (HealthDay News) — Pembrolizumab (Keytruda) may extend survival for patients with advanced non-small-cell lung cancer (NSCLC), according to a study published online Dec. 19 in The Lancet. The research was also presented at the annual meeting of the European Society for Medical Oncology, held from Dec. 18 to 21 in Singapore.
Affordable Care Act Has Improved Access to Care, Affordability
MONDAY, Dec. 21, 2015 (HealthDay News) — Implementation of the Affordable Care Act has improved access to care and affordability of care for many adults, according to a study published in the December issue of Health Affairs.
Use of Minimally Invasive Sx for Endometrial Cancer Varies
MONDAY, Dec. 21, 2015 (HealthDay News) — There is considerable variation in hospital utilization of minimally invasive surgery for the treatment of early-stage endometrial cancer, according to a study published in the January issue of Obstetrics & Gynecology.
Full Text (subscription or payment may be required)
Cryotherapy + Imiquimod Active in Cutaneous Melanoma Mets
MONDAY, Dec. 21, 2015 (HealthDay News) — Cryotherapy combined with topical imiquimod 5 percent is an active treatment for locoregional cutaneous metastases of melanoma (LCMM), according to research published online Dec. 12 in the Journal of Dermatology.
Daily Spirometry Can Give Early Warning of Pneumonia in AML
MONDAY, Dec. 21, 2015 (HealthDay News) — For patients with acute myeloid leukemia (AML), patient-performed daily spirometry (forced expiratory volume in one second [FEV1]) is effective for early identification of pneumonia, according to a study published online Dec. 10 in the American Journal of Hematology.
Acral Pigmented Lesions More Common on Darker Skin
FRIDAY, Dec. 18, 2015 (HealthDay News) — People with darker skin are about one-third more likely to have acral pigmented lesions on their palms and soles, according to a study published online Dec. 14 in the Journal of the American Academy of Dermatology.
Pepducin PZ-128 Inhibits Platelet Protease-Activated Receptor-1
FRIDAY, Dec. 18, 2015 (HealthDay News) — The pepducin PZ-128 offers rapid, specific, dose-dependent, and reversible inhibition of platelet protease-activated receptor-1, according to a study published online Dec. 17 in Arteriosclerosis, Thrombosis, and Vascular Biology.
Age at NSCLC Diagnosis Tied to Odds of Targetable Phenotype
FRIDAY, Dec. 18, 2015 (HealthDay News) — For patients with non-small-cell lung cancer (NSCLC), younger age at diagnosis is associated with increased frequency of a targetable phenotype, according to a study published online Dec. 17 in JAMA Oncology.
Ultrasound Findings in Invasive Breast CA Link to Histopathology
FRIDAY, Dec. 18, 2015 (HealthDay News) — Histopathologic patterns and biomarkers for invasive breast cancer correlate with differences in findings on sonographic (US) imaging, according to a study published in the January issue of the Journal of Clinical Ultrasound.
Longer Follow-Up Needed to Evaluate Ovarian CA Screening
THURSDAY, Dec. 17, 2015 (HealthDay News) — The efficacy of ovarian cancer screening is unclear, with no significant reduction in mortality in primary analysis, according to a study published online Dec. 17 in The Lancet.
Surgery May Beat Radiotherapy for Localized Prostate Cancer
THURSDAY, Dec. 17, 2015 (HealthDay News) — Men with localized prostate cancer are more likely to survive if they have surgery rather than radiation therapy, according to findings published online Dec. 14 in European Urology.
Full Text (subscription or payment may be required)
Contraceptive Provision Rates Low for Teen Girls on Teratogens
THURSDAY, Dec. 17, 2015 (HealthDay News) — The rates of contraceptive provision for adolescents prescribed teratogens are low, according to a review published online Dec. 16 in Pediatrics.
Full Text (subscription or payment may be required)
Antineoplastic Agent Obscures Diagnosis of Fungal Meningitis
THURSDAY, Dec. 17, 2015 (HealthDay News) — A case of cryptococcal meningitis with false-negative cerebrospinal fluid (CSF) culture results following receipt of capecitabine has been described in a case report published in the December issue of the Journal of Clinical Pharmacy and Therapeutics.
Tumor-Treating Fields Prolong Survival in Glioblastoma
WEDNESDAY, Dec. 16, 2015 (HealthDay News) — For patients with glioblastoma, addition of tumor-treating fields (TTFields) to maintenance chemotherapy is associated with significantly prolonged survival, according to a study published in the Dec. 15 issue of the Journal of the American Medical Association.
Industry Outpacing NIH in Funding Research
WEDNESDAY, Dec. 16, 2015 (HealthDay News) — There’s been a sharp rise in the number of industry-funded clinical trials and a significant decline in those financed by the U.S. government in recent years, according to findings published in the Dec. 15 issue of the Journal of the American Medical Association.
Full Text (subscription or payment may be required)
Dose-Linked Pulmonary Complications After FFP Infusion
TUESDAY, Dec. 15, 2015 (HealthDay News) — About 20 percent of patients administered fresh frozen plasma (FFP) to reverse warfarin anticoagulation develop pulmonary complications, with highest risk seen with more than three units of FFP, according to a study published online Dec. 8 in the Journal of Thrombosis and Haemostasis.
Uptake of ‘Western Lifestyle’ Tied to Rising Cancer Rates
TUESDAY, Dec. 15, 2015 (HealthDay News) — Better screening and lifestyle changes have helped to reduce the prevalence of common cancers in many high-income countries, but low- and middle-income countries are seeing those rates rise as they adopt unhealthy Western habits, according to a report published online Dec. 14 in Cancer Epidemiology, Biomarkers & Prevention.
‘Suicide Gene Therapy’ Plus Radiation Effective in Prostate CA
TUESDAY, Dec. 15, 2015 (HealthDay News) — A combination of immune-modulatory in situ gene therapy (GT) and intensity-modulated radiotherapy (IMRT) is highly effective in treating prostate cancer, according to a study published online Dec. 12 in the Journal of Radiation Oncology.
Full Text (subscription or payment may be required)
Burnout Affects About One in Three Gynecologic Oncologists
MONDAY, Dec. 14, 2015 (HealthDay News) — About one-third of gynecologic oncologists experience burnout, according to a study published in the December issue of the American Journal of Obstetrics & Gynecology.
Early Chemo Less Likely to Help Black Breast Cancer Patients
MONDAY, Dec. 14, 2015 (HealthDay News) — Neoadjuvant chemotherapy is less likely to benefit black women with breast cancer than those in other racial and ethnic groups, according to a study published online Nov. 23 in the Journal of Clinical Oncology.
New Model of Inpatient Care Can Improve Outcomes
MONDAY, Dec. 14, 2015 (HealthDay News) — Implementation of a new model of care can improve outcomes of care in medical and surgical units, according to a study published in the December issue of the Journal of Hospital Medicine.
FDA Approves Vistogard to Treat Chemotherapy Overdose
FRIDAY, Dec. 11, 2015 (HealthDay News) — Vistogard (uridine triacetate) has been approved by the U.S. Food and Drug Administration to treat an overdose of the chemotherapy drugs fluorouracil and capecitabine, commonly used to treat cancers of the breast and gastrointestinal tract.
FDA Approves Alecensa for ALK-Positive NSCLC
FRIDAY, Dec. 11, 2015 (HealthDay News) — Alecensa (alectinib) has been approved by the U.S. Food and Drug administration to treat anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer, the agency said Friday in a news release.
Toxic Skin Effects Common With EGFR-TKI Use in NSCLC
FRIDAY, Dec. 11, 2015 (HealthDay News) — For patients with non-small-cell lung cancer, treatment with epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) is associated with skin toxic effects, according to a research letter study published online Dec. 10 in JAMA Dermatology.
Full Text (subscription or payment may be required)
Industry-Led Oncology Trials May Inflate Cost-Effectiveness
FRIDAY, Dec. 11, 2015 (HealthDay News) — Pharmaceutical industry-sponsored studies are more likely to report favorable estimates in cost-effectiveness analysis (CEA) of drugs used in breast cancer treatment, according to a research letter published online Dec. 10 in JAMA Oncology.
Full Text (subscription or payment may be required)
MITF p.E318K Prevalence Similar, Regardless of CDKN2A
FRIDAY, Dec. 11, 2015 (HealthDay News) — The prevalence of MITF p.E318K is similar in patients with melanoma, irrespective of the presence of CDKN2A mutations, according to a study published online Dec. 10 in JAMA Dermatology.
Seven Behaviors Suggested to Improve ‘Art of Medicine’
FRIDAY, Dec. 11, 2015 (HealthDay News) — Seven behaviors should be implemented to improve the art of medicine, which can help improve relationships with patients, according to an article published in Family Practice Management.
Full Text
Noninvasive Scan Promising Alternative to Biopsy in Skin CA
THURSDAY, Dec. 10, 2015 (HealthDay News) — A team from Germany now reports that a new audio-visual imaging technique looks as effective as surgery for identifying melanoma metastasis. The findings were published in the Dec. 9 issue of Science Translational Medicine.
Full Text (subscription or payment may be required)
Timing May Be Key to Success for Early Breast CA Treatment
THURSDAY, Dec. 10, 2015 (HealthDay News) — The sooner early-stage breast cancer patients have surgery following their diagnosis, and chemotherapy after their surgery, the better their chances of survival, according to two studies published online Dec. 10 in JAMA Oncology.
Mindfulness Tx Aids Cancer-Linked Cognitive Impairment
THURSDAY, Dec. 10, 2015 (HealthDay News) — For breast and colorectal cancer survivors, mindfulness-based stress reduction (MBSR) is associated with improvements in cognitive function, according to a study published online Nov. 19 in the Journal of Cancer Survivorship.
Full Text (subscription or payment may be required)
Percentage of Graduates Entering GME Stable Over Past Decade
WEDNESDAY, Dec. 9, 2015 (HealthDay News) — Despite an increase in the number of U.S. medical school graduates, over the past decade the percentage entering graduate medical education (GME) training has remained stable, according to a research letter published in the Dec. 8 issue of the Journal of the American Medical Association, a theme issue on medical education.
Full Text (subscription or payment may be required)
FDA Approves Cooling Cap to Reduce Chemo-Linked Hair Loss
WEDNESDAY, Dec. 9, 2015 (HealthDay News) — The Dignitana DigniCap Cooling System cap has been approved by the U.S. Food and Drug Administration to help prevent hair loss in women undergoing chemotherapy for breast cancer.
Doctors Rally in Support of Morcellator Use Curbed by FDA
WEDNESDAY, Dec. 9, 2015 (HealthDay News) — Dozens of gynecologists, oncologists, and women’s health experts are challenging a U.S. Food and Drug Administration warning on power morcellator use for the removal of uterine fibroids.
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Depression Not Uncommon Among Resident Physicians
WEDNESDAY, Dec. 9, 2015 (HealthDay News) — More than one in four doctors-in-training may be depressed, which could put their patients at risk, according to a study published in the Dec. 8 issue of the Journal of the American Medical Association, a theme issue on medical education.
Staged Surgical Excision Superior for Treatment of Lentigo Maligna
WEDNESDAY, Dec. 9, 2015 (HealthDay News) — For patients with lentigo maligna, staged surgical excision is associated with a low rate of recurrence, according to research published online Nov. 30 in the British Journal of Dermatology.
FDA Approves Vonvendi to Treat von Willebrand Disease
TUESDAY, Dec. 8, 2015 (HealthDay News) — Vonvendi has been approved by the U.S. Food and Drug Administration to treat adults with von Willebrand disease (VWD).
Med Ed Can Be Improved for High-Value, Cost-Conscious Care
TUESDAY, Dec. 8, 2015 (HealthDay News) — The combination of effective transmission of knowledge, facilitation of reflective practice, and a supportive environment can educate physicians to deliver high-value, cost-conscious care, according to a review published in the Dec. 8 issue of the Journal of the American Medical Association, a theme issue on medical education.
CDC: Fewer Americans Struggling With Medical Bills
TUESDAY, Dec. 8, 2015 (HealthDay News) — Fewer American families are struggling to pay medical bills, according to a report from the U.S. Centers for Disease Control and Prevention’s National Center for Health Statistics (NCHS).
ADT for Prostate CA Tied to Increased Alzheimer’s Risk
TUESDAY, Dec. 8, 2015 (HealthDay News) — Androgen deprivation therapy (ADT) for prostate cancer might dramatically increase a man’s risk of developing Alzheimer’s disease, a large-scale analysis of health data suggests. The study was published online Dec. 7 in the Journal of Clinical Oncology.
U.S. Health Care Spending Increased in 2014
TUESDAY, Dec. 8, 2015 (HealthDay News) — The expansion of insurance coverage and increases in retail prescription drug spending contributed to an increase in total national health care expenditures in 2014, according to a report published online Dec. 2 in Health Affairs.
Etiology of Leukemia in Breast Cancer Survivors Explored
MONDAY, Dec. 7, 2015 (HealthDay News) — Researchers are zeroing in on factors that may increase the risk of leukemia after breast cancer treatment, according to a report published online Dec. 7 in Cancer.
FDA Approves First Generic Version of Gleevec
MONDAY, Dec. 7, 2015 (HealthDay News) — The first generic version of the cancer drug Gleevec (imatinib mesylate) has been approved by the U.S. Food and Drug Administration.
Health Highlights: Dec. 7, 2015
Guidelines Developed for Perinatal Hematologic Cancers
MONDAY, Dec. 7, 2015 (HealthDay News) — Consensus guidelines have been developed for clinical management of hematologic malignancies during the perinatal period, according to a special article published online Nov. 30 in the Journal of Clinical Oncology.
Variation in Prices of Cancer Drugs in High-Income Countries
MONDAY, Dec. 7, 2015 (HealthDay News) — The prices of cancer drugs vary greatly across high-income countries, according to a study published online Dec. 3 in The Lancet Oncology.
Excess Relative Risk of Repeat CT Scans Can Be Quantified
FRIDAY, Dec. 4, 2015 (HealthDay News) — Excess relative risk of computed tomography (CT) scans for quantification of cystic fibrosis (CF) can be calculated, according to a letter published in the Dec. 1 issue of the American Journal of Respiratory and Critical Care Medicine.
Full Text (subscription or payment may be required)
Antidepressants Don’t Adversely Affect Tamoxifen Efficacy
FRIDAY, Dec. 4, 2015 (HealthDay News) — Breast cancer survivors who take antidepressants while on tamoxifen are not at increased risk for cancer recurrence, according to research published online Dec. 1 in the Journal of the National Cancer Institute.
Low-Risk Prostate CA Patients May Not Be Monitored Properly
FRIDAY, Dec. 4, 2015 (HealthDay News) — Many men with low-risk prostate cancer who choose active surveillance may not be followed as closely as they should be, according to a study published in the Dec. 1 issue of Cancer.
Time to Tx Initiation Impacts Survival in Head, Neck Cancer
FRIDAY, Dec. 4, 2015 (HealthDay News) — For patients with head and neck squamous cell carcinoma, time to treatment initiation (TTI) impacts overall survival, according to a study published online Nov. 30 in the Journal of Clinical Oncology.
Anthracyclines More Neurotoxic Than Other Breast CA Regimens
THURSDAY, Dec. 3, 2015 (HealthDay News) — For breast cancer survivors, anthracyclines seem to have greater negative effects on certain cognitive domains and brain network connections than nonanthracycline regimens, according to a study published online Dec. 3 in JAMA Oncology.
AMA: Case Before Supreme Court Threatens Patient Privacy
THURSDAY, Dec. 3, 2015 (HealthDay News) — A case before the Supreme Court is potentially threatening patient confidentiality, according to the American Medical Association (AMA).
False-Positive Mammogram May Hint at Breast Cancer Risk Later
THURSDAY, Dec. 3, 2015 (HealthDay News) — Women who receive a false-positive result on a mammogram may be at increased risk of developing breast cancer later, according to research published online Dec. 2 in Cancer Epidemiology, Biomarkers & Prevention.
Survival Up for Patients With Stage IV Breast Cancer
WEDNESDAY, Dec. 2, 2015 (HealthDay News) — American women diagnosed with advanced, stage IV breast cancer have a better chance of survival, and are surviving longer, compared to two decades ago, according to a study published online Dec. 2 in JAMA Surgery.
Safety Concerns Linked to Herbal Medicine Use in Cancer
WEDNESDAY, Dec. 2, 2015 (HealthDay News) — For patients with cancer, use of herbal medicine has associated safety-related concerns, including direct toxic effects and increased chemosensitivity of cancer cells, according to a study published online Nov. 24 in Cancer.
Burnout Rates on the Rise for Physicians
WEDNESDAY, Dec. 2, 2015 (HealthDay News) — Burnout is a growing problem among American doctors, according to research published in the December issue of the Mayo Clinic Proceedings.
Transfusion, Mortality Link Varies With Hemoglobin Levels
WEDNESDAY, Dec. 2, 2015 (HealthDay News) — For critically ill patients, the impact of transfusion on mortality varies with hemoglobin (Hgb) levels and with the presence of comorbid heart disease, according to a study published in the Dec. 8 issue of the Journal of the American College of Cardiology.
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
USPSTF: Insufficient Evidence for Visual Skin Cancer Screening
WEDNESDAY, Dec. 2, 2015 (HealthDay News) — The U.S. Preventive Services Task Force has found that there is currently insufficient evidence to weigh the benefits and harms of visual skin cancer screening in adults. These findings form the basis of a draft recommendation statement published online Nov. 30 by the USPSTF.
Draft Evidence Review
Draft Recommendation Statement
Comment on Recommendation
Factors ID’d for Fine Needle Aspiration Diagnostic Accuracy
TUESDAY, Dec. 1, 2015 (HealthDay News) — Factors that can independently predict fine needle aspiration (FNA) diagnosis for follicular variant papillary thyroid carcinoma (FVPTC) as suspicious malignancy or malignant have been identified, according to research published online Nov. 18 in Head & Neck.
Copyright © 2016 ScoutNews, LLC. All rights reserved.
